Vicarious Surgical (RBOT) to Release Earnings on Tuesday

Key Points

• Vicarious Surgical (NYSE:RBOT) is set to announce its Q2 2025 earnings on August 12th, with analysts predicting an earnings loss of **($2.61)** per share.
• The company's previous earnings report showed a loss of **($2.58)** per share, which exceeded the consensus estimate by **$0.03**.
• Vicarious Surgical operates a unique **single-incision surgical robot** aimed at minimizing invasive surgical procedures, contributing to the innovative landscape of medical robotics.

Vicarious Surgical (NYSE:RBOT - Get Free Report) is expected to issue its Q2 2025 quarterly earnings data after the market closes on Tuesday, August 12th. Analysts expect the company to announce earnings of ($2.61) per share for the quarter.

Vicarious Surgical (NYSE:RBOT - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported ($2.58) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.61) by $0.03. On average, analysts expect Vicarious Surgical to post $-11 EPS for the current fiscal year and $-9 EPS for the next fiscal year.

Vicarious Surgical Stock Up 3.8%

RBOT stock traded up $0.34 during trading on Friday, reaching $9.26. The company's stock had a trading volume of 9,264 shares, compared to its average volume of 35,273. Vicarious Surgical has a 1 year low of $4.27 and a 1 year high of $19.00. The company has a market capitalization of $54.88 million, a P/E ratio of -0.89 and a beta of 1.41. The company's fifty day moving average is $8.67 and its 200-day moving average is $8.97.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.